Efavirenz
- Product NDC
- 42543-889
- 11-digit product format
- 425430889
- Labeler code
- 42543
- Product ID
- 42543-889_2eb82d5c-feff-413e-9966-ab5498ae86bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Efavirenz
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Strides Pharma Inc.
- Application
- ANDA204869
- Marketing category
- ANDA
- Marketing start
- 2021-01-11
- Marketing end
- 0000-00-00
- Substance
- EFAVIRENZ
- Active strength
- 600 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42543-889-04 | 42543088904 | 30 TABLET in 1 BOTTLE (42543-889-04) | 30 tablet | 2021-01-11 | 0000-00-00 | No | No | Current |